ERBB2 and neoplasm: These three tumor xenografts provide different types of tumor origin (breast versus ovarian), receptor expression (HER2+ versus triple negative) and tumor microenvironments (high versus low vascularity and collagen content) to demonstrate breast tumor contrast enhancement in vivo using photon-counting micro-CT.